Current Approaches to the Treatment of Hunter Syndrome

Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is an X-linked hereditary disorder associated with a deficiency of iduronate2-sulfatase (IDS). IDS deficiency provokes the accumulation of dermatan sulfate and heparan sulfate in different tissues. Clinical manifestations of MPS II are heteroge...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ekaterina Yu. Zakharova, Elena Yu. Voskoboeva, Alla N. Semyachkina, Nato D. Vashakmadze, Amina I. Gamzatova, Svetlana V. Mikhailova, Sergey I. Kutsev
Format: Artigo
Sprache:Inglês
Veröffentlicht: Paediatrician Publishers, LLC 2018-10-01
Schriftenreihe:Pediatričeskaâ Farmakologiâ
Schlagworte:
hunter syndrome
mucopolysaccharidosis type ii
enzyme replacement therapy
gene therapy
hematopoietic stem cell transplantation
Online Zugang:https://www.pedpharma.ru/jour/article/view/1653
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge